Maa: Malta
Kieli: englanti
Lähde: Medicines Authority
ATORVASTATIN
KRKA DD Novo Mesto Šmarješka cesta 6, 8501 Novo mesto, Slovenia
C10AA05
ATORVASTATIN 40 mg
FILM-COATED TABLET
ATORVASTATIN 40 mg
POM
LIPID MODIFYING AGENTS
Withdrawn
2009-09-22
Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ATORVASTATIN KRKA 10 MG FILM-COATED TABLETS ATORVASTATIN KRKA 20 MG FILM-COATED TABLETS ATORVASTATIN KRKA 40 MG FILM-COATED TABLETS Atorvastatin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Atorvastatin Krka is and what it is used for 2. What you need to know before you take Atorvastatin Krka 3. How to take Atorvastatin Krka 4. Possible side effects 5. How to store Atorvastatin Krka 6. Contents of the pack and other information 1. WHAT ATORVASTATIN KRKA IS AND WHAT IT IS USED FOR Atorvastatin Krka belongs to a group of medicines known as statins, which are lipid (fat) regulating medicines. Atorvastatin Krka is used to lower lipids known as cholesterol and triglycerides in the blood when a low fat diet and life style changes on their own have failed. If you are at an increased risk of heart disease, Atorvastatin Krka can also be used to reduce such risk even if your cholesterol levels are normal. You should maintain a standard cholesterol lowering diet during treatment. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ATORVASTATIN KRKA DO NOT TAKE ATORVASTATIN KRKA - if you are allergic to atorvastatin or to any similar medicines use Lue koko asiakirja
Page 1 of 22 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Atorvastatin Krka 10 mg film-coated tablets Atorvastatin Krka 20 mg film-coated tablets Atorvastatin Krka 40 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Atorvastatin Krka 10 mg film-coated tablets Each film-coated tablet contains 10 mg atorvastatin as atorvastatin calcium. Atorvastatin Krka 20 mg film-coated tablets Each film-coated tablet contains 20 mg atorvastatin as atorvastatin calcium. Atorvastatin Krka 40 mg film-coated tablets Each film-coated tablet contains 40 mg atorvastatin as atorvastatin calcium. Excipient with known effect: 10 mg tablets 20 mg tablets 40 mg tablets Lactose monohydrate (mg/tablet) 56.9 113.8 227.6 For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. 10 mg tablets: White, round, slightly convex, bevel-edged, with diameter 6 mm. 20 mg tablets: White, round, slightly convex, bevel-edged, with diameter 8 mm. 40 mg tablets: White, round, slightly convex, bevel-edged, with diameter 10 mm. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypercholesterolaemia Atorvastatin Krka is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-C), LDL-cholesterol (LDL-C), apolipoprotein B, and triglycerides in adults, adolescents and children aged 10 years or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to Types IIa and IIb of the Fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Page 2 of 22 Atorvastatin Krka is also indicated to reduce total-C and LDL-C in adults with ho Lue koko asiakirja